Abstract

Like other pathogens that readily persist in animal hosts, members of the Bornaviridae family have evolved effective mechanisms to evade the innate immune response. The prototype of this virus family, Borna disease virus employs an unusual replication strategy that removes the triphosphates from the 5′ termini of the viral RNA genome. This strategy allows the virus to avoid activation of RIG-I and other innate immune response receptors in infected cells. Here we determined whether the newly discovered avian bornaviruses (ABV) might use a similar strategy to evade the interferon response. We found that de novo infection of QM7 and CEC32 quail cells with two different ABV strains was efficiently inhibited by exogenous chicken IFN-α. IFN-α also reduced the viral load in QM7 and CEC32 cells persistently infected with both ABV strains, suggesting that ABV is highly sensitive to type I IFN. Although quail cells persistently infected with ABV contained high levels of viral RNA, the supernatants of infected cultures did not contain detectable levels of biologically active type I IFN. RNA from cells infected with ABV failed to induce IFN-β synthesis if transfected into human cells. Furthermore, genomic RNA of ABV was susceptible to 5′-monophosphate-specific RNase, suggesting that it lacks 5′-triphospates like BDV. These results indicate that bornaviruses of mammals and birds use similar strategies to evade the host immune response.

Highlights

  • All successful persisting viruses must possess some efficient means to evade the immune system of the host

  • Viruses such as hepatitis C virus face similar difficulties during replication in liver cells which they solve with the help of virus-encoding factors that greatly limit the synthesis of type I interferon (IFN)

  • RNA prepared from avian bornaviruses (ABV) or Borna disease virus (BDV) stocks exhibited a high degree of susceptibility to Terminator, whereas RNA prepared from Rift valley fever virus (RVFV) stocks exhibited a high degree of resistance to this exonuclease (Figure 5B)

Read more

Summary

Introduction

All successful persisting viruses must possess some efficient means to evade the immune system of the host. BDV may suppress the synthesis of substantial amounts of type I IFN in infected brains To distinguish between these two possibilities, infection studies were performed with transgenic mice that constitutively express an IFN gene in astrocytes. Unterstab and coworkers [6] found that the P protein of BDV can inhibit the activity of TBK1, the principal regulatory kinase that activates IRF3 which is required for RIG-I-dependent induction of IFN genes in virus-infected cells. These results suggested that BDV-P may act as a decoy target for TBK1. No information regarding how ABV might cope with the IFN system of avian host cells has to date been available

Results and Discussion
Type I IFN prevents efficient spread of ABV to uninfected quail cells
Type I IFN inhibits the activity of ABV in persistently infected quail cells
Inefficient activation of type I IFN genes in ABV-infected quail cells
No evidence for triphosphorylated 5’-termini of ABV genomic RNA
Viruses
Production of antiserum against ABV-N
Cell lines and culture conditions
Measuring IFN- gene induction after RNA transfection
Digestion of RNA with 5’-monophosphate specific RNase
Detection of ABV-infected cells by immunofluorescence analysis
Detection of ABV-N in QM-7 cell lysates by Western blotting
3.10. IFN induction using SC35M-delNS1
3.11. Northern blot analysis
Conclusions

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.